Immunic, Inc. (IMUX)

Immunic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	55.31	35.67	46.67	106.75	86.86	127.45
Short-Term Investments	-	-	-	9.63	-	-
Cash & Short-Term Investments	55.31	35.67	46.67	116.37	86.86	127.45
Cash Growth	-30.60%	-23.58%	-59.89%	33.97%	-31.85%	333.97%
Other Receivables	0.59	0.68	2.48	2.66	2.15	1.64
Receivables	0.59	0.68	2.48	2.66	2.15	1.64
Prepaid Expenses	3.08	1.87	2.31	5.61	15.98	4.65
Other Current Assets	0.86	1.11	1.07	1.23	-	-
Total Current Assets	59.84	39.33	52.53	125.86	104.99	133.75
Property, Plant & Equipment	1.59	1.54	1.77	1.85	1.1	1.1
Goodwill	-	-	-	-	32.97	32.97
Other Long-Term Assets	-	-	-	0.04	0.04	0.04
Total Assets	61.43	40.87	54.3	127.75	139.1	167.86
Accounts Payable	7.89	7.85	5.1	4.28	3.75	3.7
Accrued Expenses	18.11	12.91	18.66	7.99	7.07	4.32
Current Portion of Leases	0.77	0.74	0.7	0.57	0.41	0.3
Other Current Liabilities	0.53	0.68	0.27	0.24	0.18	0.08
Total Current Liabilities	27.31	22.18	24.73	13.08	11.4	8.4
Long-Term Leases	0.21	0.26	0.64	0.99	0.58	0.68
Total Liabilities	27.52	22.44	25.37	14.07	11.99	9.08
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	595.07	525.61	436.06	427.93	324.24	266.82
Retained Earnings	-563.69	-511.4	-410.89	-317.28	-196.87	-103.93
Comprehensive Income & Other	2.53	4.21	3.76	3.04	-0.25	-4.11
Total Common Equity	33.91	18.43	28.93	113.68	127.12	158.79
Shareholders' Equity	33.91	18.43	28.93	113.68	127.12	158.79
Total Liabilities & Equity	61.43	40.87	54.3	127.75	139.1	167.86
Total Debt	0.98	1	1.33	1.56	0.99	0.98
Net Cash (Debt)	54.33	34.66	45.34	114.81	85.87	126.48
Net Cash Growth	-31.00%	-23.55%	-60.51%	33.70%	-32.10%	338.41%
Net Cash Per Share	0.50	0.35	1.02	3.61	3.63	8.07
Filing Date Shares Outstanding	98.65	90.15	89.93	44.4	27.91	21.17
Total Common Shares Outstanding	98.65	90.15	45.18	39.31	26.34	21.17
Working Capital	32.53	17.16	27.81	112.79	93.59	125.35
Book Value Per Share	0.34	0.20	0.64	2.89	4.83	7.50
Tangible Book Value	33.91	18.43	28.93	113.68	94.15	125.82
Tangible Book Value Per Share	0.34	0.20	0.64	2.89	3.57	5.94

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q